What Total PSA Tells You
Total PSA is a blood test that measures a prostate-produced protein and indicates your risk of having prostate cancer, though it cannot definitively diagnose cancer since PSA elevates in both benign and malignant prostate conditions.
Understanding PSA as a Risk Indicator
Total PSA functions as a continuous risk marker rather than a simple positive/negative test 1. The higher your PSA, the greater your probability of harboring prostate cancer:
- 0-2.0 ng/mL: ~10% cancer risk
- 2.0-4.0 ng/mL: 15-25% cancer risk
- 4.0-10.0 ng/mL: 17-32% cancer risk
- >10.0 ng/mL: 43-65% cancer risk 1
Critically, even "low" PSA values carry cancer risk - men with PSA ≤4.0 ng/mL still have a 6-27% chance of prostate cancer, with 10-25% of those being high-grade cancers 1.
Age and Ethnicity Matter
PSA naturally increases with age, so interpretation requires context 1:
Age-Specific Reference Ranges:
- 40-49 years: 0-2.0 to 2.5 ng/mL (varies by ethnicity)
- 50-59 years: 0-3.0 to 4.0 ng/mL
- 60-69 years: 0-4.0 to 4.5 ng/mL
- 70-79 years: 0-5.0 to 6.5 ng/mL
African-American men and those with family history face higher baseline risk and may warrant different thresholds 1.
What PSA Does NOT Tell You
PSA is organ-specific but not cancer-specific 2, 3. Elevated PSA occurs in:
- Benign prostatic hyperplasia (BPH) - accounts for ~2/3 of elevated values in men >50 years 3
- Prostatitis
- Recent prostate biopsy (wait 3-6 weeks before testing) 1
- Urinary tract infections
Important caveat: Medications like finasteride and dutasteride lower PSA by ~50%, requiring adjustment in interpretation 1.
The Screening Controversy
Current guidelines recommend AGAINST routine systematic PSA screening 4. The 2018 CAP trial showed no significant reduction in prostate cancer mortality after 10 years of screening, while detecting more low-risk cancers that may never cause harm 4.
However, this creates a nuanced clinical situation: shared decision-making is essential 4. Men at higher risk (African descent, strong family history) or those highly concerned about ruling out cancer may reasonably choose screening despite the weak overall recommendation against it 4.
Laboratory Variability Warning
PSA assays are NOT interchangeable - results can vary 20-25% between different laboratory standards 1. Always use the same assay for monitoring over time, and consider confirming an abnormal result before proceeding to biopsy 1.
Beyond the Single Number
Total PSA alone has limited specificity (60-70% at 4.0 ng/mL cutoff) 1. Additional factors improve interpretation:
- Free PSA ratio: Lower ratios (<0.25) suggest higher cancer risk 3, 5
- PSA velocity: Requires ≥3 values over ≥18 months 1
- Digital rectal exam findings
- Family history and ethnicity
The decision to biopsy should never rely on PSA alone but rather on individualized risk assessment incorporating multiple factors 1.